.png
)
Doc No. CDSCO/MD/GD/MDSW/01/2026 | Circular F. No. MED-16028/2/2025-eoffice dated 21.07.2026 The Central Drugs Standard Control Organization (CDSCO), Medical Devices Division, has notified the final Guidance Document on Medical Device Software (MDSW), signed by Dr. Rajeev Singh Raghuvanshi, Drugs Controller General…
Regulatory Update | CDSCO / DCC | July 2026 The Drugs Consultative Committee (DCC), at its 69th meeting, took up a proposal aimed at tightening control over one of the least regulated links in the pharmaceutical supply chain: the manufacturers…
High-Alcohol Oral Formulations Move Into Schedule H1: What G.S.R. 607(E) Means for Manufacturers The Drugs (Tenth Amendment) Rules, 2026 tighten the exemption net around alcohol-based oral medicines — and bring a familiar public health concern squarely into prescription-drug territory. Notification:…
CDSCO · Drugs Rules Amendment · GSR 506(E) Schedule H2 Expanded: Vaccines, Antimicrobials, Narcotic Drugs & Anticancer Medicines Now Under Stricter Prescription Controls 📅 Gazette Date: 22 June 2026 ⚖️ Effective: 1 July 2027 (Antimicrobials: 1 July 2028) 🏛 Ministry…
CDSCO Circular: Supply of IVF Media & ART Consumables Restricted to Registered Centres Only | Vaayath Consulting Regulatory Update · Medical Devices CDSCO Directs Stakeholders: IVF Media, Reagents & ART Consumables Must Be Supplied Only to Registered Centres 📅 23…